Annis Gardner Whiting Capital Advisors’s Dentsply Sirona XRAY Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$47	Buy	+4	New	+$50	﹤0.01%	1312

Other funds holding XRAY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's XRAY Position: Q1 2026 in Review

Annis Gardner Whiting Capital Advisors opened a new position in Dentsply Sirona (XRAY) in Q1 2026: 4 shares worth $47. The stake represents ﹤0.01% of the portfolio and ranks #1312 among its holdings.

382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

Annis Gardner Whiting Capital Advisors held 4 shares of Dentsply Sirona worth $47 as of Q1 2026.
Dentsply Sirona was a new Annis Gardner Whiting Capital Advisors position in Q1 2026.
Dentsply Sirona made up ﹤0.01% of Annis Gardner Whiting Capital Advisors's portfolio in Q1 2026, its #1312 holding.
382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q1 2026, filed 6 May 2026.